Holocene Advisors
BLTE

Holocene Advisors’s Belite Bio BLTE Stock Holding History

Holocene Advisors’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7M Sell
251,035
-243,460
-49% -$37.3M 0.09% 222
2026
Q1 		$78.8M Buy
494,495
+410,428
+488% +$69M 0.19% 134
2025
Q4 		$13.4M Buy
+84,067
New +$9.96M 0.03% 310

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Holocene Advisors's BLTE Position: Q2 2026 in Review

Holocene Advisors reduced its Belite Bio (BLTE) stake by 49% in Q2 2026, selling an estimated $37.3M and leaving 251,035 shares worth $38.7M. The position accounts for 0.09% of the portfolio, ranked #222.

Holocene Advisors first reported a position in BLTE in Q4 2025 and has held it in 3 quarters since. The position peaked at $78.8M in Q1 2026. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Holocene Advisors held 251,035 shares of Belite Bio worth $38.7M as of Q2 2026.
  • Holocene Advisors sold 243,460 Belite Bio shares in Q2 2026, an estimated $37.3M.
  • Belite Bio made up 0.09% of Holocene Advisors's portfolio in Q2 2026, its #222 holding.
  • Holocene Advisors first reported a position in Belite Bio in Q4 2025 and has held it in 3 quarters since.
  • Holocene Advisors's Belite Bio position peaked at $78.8M in Q1 2026.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.